NIH #5R44HG013071-03
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples
Expiring Soon
- Amount
- $1.0M
- Period
- 2023-05-01 → 2026-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #2R44HG013071-02
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples
Expiring Soon
- Amount
- $1.0M
- Period
- 2023-05-01 → 2026-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44HG011875-03
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
- Amount
- $1.0M
- Period
- 2022-02-01 → 2026-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #3R44HG011875-03S1
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
- Amount
- $185K
- Period
- 2022-02-01 → 2026-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44GM148145-03
Multiomic genomic mapping with long read sequencing
- Amount
- $1.3M
- Period
- 2022-09-01 → 2025-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #4R44GM148145-02
Multiomic genomic mapping with long read sequencing
- Amount
- $1.3M
- Period
- 2022-09-01 → 2025-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44AI167215-03
Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells
- Amount
- $998K
- Period
- 2022-08-18 → 2025-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44AI167215-02
Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells
- Amount
- $1.0M
- Period
- 2022-08-18 → 2025-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R44AI167215-01A1
Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells
- Amount
- $1.0M
- Period
- 2022-08-18 → 2025-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44GM131560-03
Quantification of combinatorial epigenetic modifications using defined nucleosome standards
- Amount
- $1.0M
- Period
- 2019-01-01 → 2025-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44AI162386-03
A new epigenetic toolbox for inflammation research and drug discovery
- Amount
- $1.0M
- Period
- 2021-05-05 → 2025-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44TR004227-02
A molecular toolbox to accelerate drug development for histone lysine methylation regulators
- Amount
- $1.0M
- Period
- 2022-05-01 → 2025-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #4R44HG011875-02
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
- Amount
- $1.0M
- Period
- 2022-02-01 → 2025-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #3R44HG011875-02S1
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
- Amount
- $96K
- Period
- 2023-08-01 → 2025-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R43HG013071-01
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples
- Amount
- $406K
- Period
- 2023-05-01 → 2024-09-09
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44HG010640-03
Development of efficient quantitative chromatin profiling in kit and high-throughput formats
- Amount
- $1.0M
- Period
- 2020-09-01 → 2024-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R43AG076049-01
High-resolution genomic mapping of ssDNA and associated proteins for Alzheimer's disease research
- Amount
- $500K
- Period
- 2022-09-01 → 2024-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44HG010595-03
Quantitative mapping of combinatorial histone modifications
- Amount
- $1.0M
- Period
- 2019-06-12 → 2024-08-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #2R44GM131560-02
Quantification of combinatorial epigenetic modifications using defined nucleosome standards
- Amount
- $1.0M
- Period
- 2019-01-01 → 2024-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R44TR004227-01
A molecular toolbox to accelerate drug development for histone lysine methylation regulators
- Amount
- $1.0M
- Period
- 2022-05-01 → 2024-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44AI162386-02
A new epigenetic toolbox for inflammation research and drug discovery
- Amount
- $1.0M
- Period
- 2021-05-05 → 2024-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R44AI162386-01
A new epigenetic toolbox for inflammation research and drug discovery
- Amount
- $1.0M
- Period
- 2021-05-05 → 2024-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R44GM148145-01
Multiomic genomic mapping with long read sequencing
- Amount
- $406K
- Period
- 2022-09-01 → 2023-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44DE029633-03
Development of novel spike-in controls for quantitative chromatin-associated protein profiling
- Amount
- $978K
- Period
- 2019-09-13 → 2023-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #4R44HG010640-02
Development of efficient quantitative chromatin profiling in kit and high-throughput formats
- Amount
- $1.0M
- Period
- 2020-09-01 → 2023-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #2R44HG010595-02
Quantitative mapping of combinatorial histone modifications
- Amount
- $1.0M
- Period
- 2019-06-12 → 2023-08-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R44HG011875-01A1
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
- Amount
- $426K
- Period
- 2022-02-01 → 2023-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #3R44HG011875-01A1S1
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
- Amount
- $104K
- Period
- 2022-02-01 → 2023-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44HG011006-02
Quantitative and highly versatile chromatin accessibility platform
- Amount
- $876K
- Period
- 2019-12-05 → 2022-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #4R44DE029633-02
Development of novel spike-in controls for quantitative chromatin-associated protein profiling
- Amount
- $978K
- Period
- 2019-09-13 → 2022-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R43CA232941-01A1
Quantitative assessment of response to epigenetic-targeted therapy
- Amount
- $300K
- Period
- 2019-06-01 → 2022-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R44HG011006-01
Quantitative and highly versatile chromatin accessibility platform
- Amount
- $910K
- Period
- 2019-12-05 → 2021-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R44HG010640-01A1
Development of efficient quantitative chromatin profiling in kit and high-throughput formats
- Amount
- $397K
- Period
- 2020-09-01 → 2021-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44CA214076-03
A novel protein engineering tool for rapid manufacturing of designer nucleosomes
- Amount
- $985K
- Period
- 2016-09-20 → 2021-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44GM123869-03
A nucleosome sliding assay platform to screen inhibitors of SWI/SNF chromatin remodeling complexes
- Amount
- $854K
- Period
- 2017-06-01 → 2021-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R43GM131560-01
Quantification of combinatorial epigenetic modifications using defined nucleosome standards
- Amount
- $300K
- Period
- 2019-01-01 → 2020-12-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R44DE029633-01
Development of novel spike-in controls for quantitative chromatin-associated protein profiling
- Amount
- $259K
- Period
- 2019-09-13 → 2020-09-12
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #2R44CA214076-02
A novel protein engineering tool for rapid manufacturing of designer nucleosomes
- Amount
- $1000K
- Period
- 2016-09-20 → 2020-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R43HG010595-01
Quantitative mapping of combinatorial histone modifications
- Amount
- $285K
- Period
- 2019-06-12 → 2020-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #2R44GM123869-02
A nucleosome sliding assay platform to screen inhibitors of SWI/SNF chromatin remodeling complexes
- Amount
- $866K
- Period
- 2017-06-01 → 2020-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R43GM126724-01
Aptamer Beacons For High-Throughput Assay Development
- Amount
- $300K
- Period
- 2018-03-01 → 2020-02-29
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R43HG009768-01
Next-Generation Detection Reagents for Chromatin Immunoprecipitation
- Amount
- $225K
- Period
- 2017-08-01 → 2018-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #1R43GM123869-01
A nucleosome sliding assay platform to screen inhibitors of SWI/SNF chromatin remodeling complexes
- Amount
- $225K
- Period
- 2017-06-01 → 2018-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.
NIH #5R44HG008907-02
Internally Calibrated Chromatin Immunoprecipitation Using Barcoded Nucleosomes
- Amount
- $663K
- Period
- 2015-12-15 → 2017-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EPICYPHER, INC.